SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010362
Filing Date
2015-11-10
Accepted
2015-11-10 17:01:07
Documents
15
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20150930.htm 10-Q 1961486
2 EX-10.1 xene-ex101_117.htm EX-10.1 79525
3 EX-31.1 xene-ex311_6.htm EX-31.1 16262
4 EX-31.2 xene-ex312_9.htm EX-31.2 16591
5 EX-32.1 xene-ex321_10.htm EX-32.1 8439
6 EX-32.2 xene-ex322_7.htm EX-32.2 8253
7 GRAPHIC g201511092303389642785.jpg GRAPHIC 21654
8 GRAPHIC g201511092303389492784.jpg GRAPHIC 23653
9 GRAPHIC g201511092303389802786.jpg GRAPHIC 33991
  Complete submission text file 0001564590-15-010362.txt   4297385

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT xene-20150930.xml EX-101.INS 586424
11 XBRL TAXONOMY EXTENSION SCHEMA xene-20150930.xsd EX-101.SCH 24961
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20150930_cal.xml EX-101.CAL 31507
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20150930_def.xml EX-101.DEF 40820
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20150930_lab.xml EX-101.LAB 187631
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20150930_pre.xml EX-101.PRE 134783
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 151219614
SIC: 2834 Pharmaceutical Preparations